About granisetron injection
Granisetron injection is a potent 5-HT3 receptor antagonist used to prevent nausea and vomiting associated with cancer chemotherapy, radiation therapy, and surgery. It acts by blocking serotonin, a substance that triggers vomiting. It is administered intravenously or subcutaneously by healthcare professionals, with common side effects including headache, constipation, and injection site
Reliable Protection Against Nausea and VomitingGranisetron injection delivers effective relief and prevention of nausea and vomiting triggered by chemotherapy, radiotherapy, and surgical procedures. Its rapid action when administered intravenously makes it a dependable choice in clinical settings, providing comfort and improved quality of care for patients.
Convenient Administration and StorageThis sterile, allopathic formulation is ready for intravenous or infusion use, ensuring flexibility for healthcare providers. Available in portable ampoules and packaged in boxes for convenient handling, it requires storage below 30C and protection from light, ensuring maintained efficacy and extended shelf life.
FAQ's of granisetron injection:
Q: How is granisetron injection administered and who can receive it?
A: Granisetron injection is given as a single intravenous (IV) dose or via infusion, typically before chemotherapy, radiotherapy, or surgery. It is suitable for both adults and children, as directed by a physician.
Q: What conditions does granisetron injection treat or prevent?
A: This medication is recommended for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and surgical procedures.
Q: When should granisetron injection be used?
A: Granisetron injection should be administered shortly before exposure to treatments or procedures known to cause nausea and vomiting, according to the dosing schedule provided by a healthcare professional.
Q: What are the available strengths and packaging options for granisetron injection?
A: Granisetron injection is available in 1 mg/ml and 3 mg/ml strengths and comes in 1 ml and 3 ml clear ampoules, with five ampoules packed per box.
Q: Where should granisetron injection be stored to preserve its effectiveness?
A: The ampoules should be stored below 30C and protected from light, as per storage instructions, to ensure they remain effective throughout the 24-month shelf life.
Q: What steps should be taken if a patient is hypersensitive to granisetron?
A: Granisetron injection is contraindicated in patients with known hypersensitivity to granisetron. Alternative antiemetic therapies should be considered under the guidance of a physician.
Q: What is the main benefit of using granisetron injection?
A: The chief benefit of granisetron injection is its ability to prevent and control nausea and vomiting promptly and effectively, improving patient comfort during cancer treatments and surgical interventions.